BIOMAT Database Logo BIOMAT Database Logo

A novel series of synthetic thrombin-inhibitors having extremely potent and highly selective action. 1975

S Okamoto, and A Hijikata, and K Kinjo, and R Kikumoto, and K Okubo

UI MeSH Term Description Entries
D003619 Dansyl Compounds Compounds that contain a 1-dimethylaminonaphthalene-5-sulfonyl group. Dimethylaminonaphthalenesulfonyl Compounds,Compounds, Dansyl,Compounds, Dimethylaminonaphthalenesulfonyl
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D000991 Antithrombins Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins. Antithrombin,Direct Antithrombin,Direct Antithrombins,Direct Thrombin Inhibitor,Direct Thrombin Inhibitors,Antithrombin, Direct,Antithrombins, Direct,Inhibitor, Direct Thrombin,Thrombin Inhibitor, Direct,Thrombin Inhibitors, Direct
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate

Related Publications

S Okamoto, and A Hijikata, and K Kinjo, and R Kikumoto, and K Okubo
Novel bicyclic lactam inhibitors of thrombin: highly potent and selective inhibitors.
April 2002, Bioorganic & medicinal chemistry letters,
S Okamoto, and A Hijikata, and K Kinjo, and R Kikumoto, and K Okubo
Novel inhibitors of IMPDH: a highly potent and selective quinolone-based series.
February 2003, Bioorganic & medicinal chemistry letters,
S Okamoto, and A Hijikata, and K Kinjo, and R Kikumoto, and K Okubo
Design and synthesis of potent and highly selective thrombin inhibitors.
November 1994, Journal of medicinal chemistry,
S Okamoto, and A Hijikata, and K Kinjo, and R Kikumoto, and K Okubo
Discovery of a Novel Series of Thienopyrimidine as Highly Potent and Selective PI3K Inhibitors.
April 2015, ACS medicinal chemistry letters,
S Okamoto, and A Hijikata, and K Kinjo, and R Kikumoto, and K Okubo
A novel series of potent and selective IKK2 inhibitors.
January 2004, Bioorganic & medicinal chemistry letters,
S Okamoto, and A Hijikata, and K Kinjo, and R Kikumoto, and K Okubo
A series of novel, potent, and selective histone deacetylase inhibitors.
December 2006, Bioorganic & medicinal chemistry letters,
S Okamoto, and A Hijikata, and K Kinjo, and R Kikumoto, and K Okubo
Discovery of novel N-acylpyrazoles as potent and selective thrombin inhibitors.
January 2023, European journal of medicinal chemistry,
S Okamoto, and A Hijikata, and K Kinjo, and R Kikumoto, and K Okubo
Liporetro-D-peptides - a novel class of highly selective thrombin inhibitors.
April 2012, Thrombosis research,
S Okamoto, and A Hijikata, and K Kinjo, and R Kikumoto, and K Okubo
Highly selective tripeptide thrombin inhibitors.
February 1993, Journal of medicinal chemistry,
S Okamoto, and A Hijikata, and K Kinjo, and R Kikumoto, and K Okubo
A novel series of highly selective inhibitors of MMP-3.
December 2007, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!